Crossmark Global Holdings Inc. Has $778,000 Position in Takeda Pharmaceutical Company Limited (NYSE:TAK)

Crossmark Global Holdings Inc. raised its stake in Takeda Pharmaceutical Company Limited (NYSE:TAK) by 57.9% in the 3rd quarter, Holdings Channel.com reports. The fund owned 54,689 shares of the company’s stock after buying an additional 20,055 shares during the quarter. Crossmark Global Holdings Inc.’s holdings in Takeda Pharmaceutical were worth $778,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently modified their holdings of TAK. EverSource Wealth Advisors LLC raised its stake in Takeda Pharmaceutical by 38.6% in the second quarter. EverSource Wealth Advisors LLC now owns 3,082 shares of the company’s stock valued at $43,000 after purchasing an additional 859 shares in the last quarter. Headlands Technologies LLC acquired a new position in shares of Takeda Pharmaceutical in the 2nd quarter valued at approximately $59,000. Hexagon Capital Partners LLC lifted its holdings in shares of Takeda Pharmaceutical by 34.3% during the 3rd quarter. Hexagon Capital Partners LLC now owns 4,419 shares of the company’s stock worth $63,000 after acquiring an additional 1,129 shares during the period. Blue Trust Inc. boosted its position in shares of Takeda Pharmaceutical by 74.0% during the 2nd quarter. Blue Trust Inc. now owns 5,480 shares of the company’s stock worth $76,000 after acquiring an additional 2,330 shares in the last quarter. Finally, Ridgewood Investments LLC bought a new position in Takeda Pharmaceutical in the second quarter valued at approximately $89,000. 9.17% of the stock is currently owned by institutional investors.

Takeda Pharmaceutical Stock Up 0.4 %

Shares of TAK opened at $13.62 on Friday. The firm has a 50 day simple moving average of $14.27 and a two-hundred day simple moving average of $13.82. The company has a market cap of $43.34 billion, a P/E ratio of 23.33, a P/E/G ratio of 0.26 and a beta of 0.54. Takeda Pharmaceutical Company Limited has a one year low of $12.57 and a one year high of $15.08. The company has a debt-to-equity ratio of 0.64, a current ratio of 1.28 and a quick ratio of 0.77.

About Takeda Pharmaceutical

Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived therapies, immunology, oncology, and neuroscience.